Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Translational Research

Drug boosts survival when breast cancer spreads to brain

Treatment with lapatinib could extend survival in women with Her2-positive breast cancer that has spread to the brain, according to research published today in the British...

Cardiff scientists take on leukaemia with drugs personalised to individual patients

Cardiff scientists are treating leukaemia by trialling new drugs tailored to individual patientsї genetic make-up.

Common anti-fungal drug found to stop blood vessel growth

A drug commonly used to treat toenail fungus can also block the growth of new blood vessels, researchers have discovered.

Strategy to conquer cancer drug resistance uncovered

US scientists have identified a way in which cancer cells can become resistant to the cancer drug cetuximab (Erbitux), and suggest that treatments that are already...

'Skills Swap' to exploit expertise for patient benefit

Cancer Research Technology (CRT) and Medical Research Council Technology (MRCT) will 'swap' medical discoveries to accelerate the translation of early scientific research...

Cancer Research UK launches trial to treat brain cancer which has returned

Cancer Research UKїs Drug Development Office has opened a trial of a new combination of drugs for the treatment of patients with brain cancer.

Radiotherapy before surgery slashes bowel cancer recurrence says trial

An international clinical trial has found a way to minimise the risk of tumour recurrence in bowel cancer patients to as little as one per cent.

'Targeted' breast and ovarian cancer drug could have far wider application

Canadian researchers have shown that the targeted cancer drug olaparib can also reduce the size of tumours in a substantial minority of ovarian cancer patients.

Temozolomide sales reach $1 billion

Sales of Temozolomide*, an anti-cancer drug developed by Cancer Research UK scientists, have reached $1 billion**.

Cancer Research UK and AstraZeneca sign deal to trial first-of-kind cancer drug

Cancer Research UK and Cancer Research Technology have reached an agreement with AstraZeneca to take compound AZD-3965, a first-of-its-kind experimental drug to...

Pages